Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Designer Brands Inc. due to allegations of materially misleading business information issued to the investing public [1]. Group 1: Legal Action and Investor Rights - Shareholders who purchased Designer Brands securities may be entitled to compensation through a contingency fee arrangement, with no out-of-pocket costs [2]. - A class action is being prepared by Rosen Law Firm to seek recovery of investor losses [2]. Group 2: Financial Performance and Market Reaction - Designer Brands reported a soft start to 2025, citing an unpredictable macro environment and deteriorating consumer sentiment, leading to the withdrawal of its 2025 guidance [3]. - Following the announcement of these results, Designer Brands' stock experienced a significant decline of 18.2% on June 10, 2025 [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Savara Inc. securities between March 7, 2024, and May 23, 2025, of the upcoming lead plaintiff deadline on November 7, 2025, for a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Savara securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 7, 2025 [2] - The lawsuit claims that Savara's defendants made false or misleading statements regarding the approval process of the MOLBREEVI Biologics License Application (BLA) [4] Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success and recognition in this field [3] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3] - Investors have the option to select their counsel or remain absent from the class until it is certified [6]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fluor Corporation securities between February 18, 2025, and July 31, 2025, about the upcoming lead plaintiff deadline on November 14, 2025, for a class action lawsuit [1][2] Group 1: Class Action Details - Investors who purchased Fluor securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the November 14, 2025 deadline [2][4] - The lawsuit alleges that Fluor made false and misleading statements regarding project costs and financial guidance, which negatively impacted its business and financial results [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has consistently ranked highly in securities class action settlements [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fly-E Group, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the Fly-E Group, Inc. securities is from July 15, 2025, to August 14, 2025, inclusive [1]. - Investors who purchased Fly-E securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 10, 2025 [2]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [3]. - Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [3]. Group 3: Case Allegations - The lawsuit alleges that Fly-E Group provided misleading statements regarding the safety of its lithium battery, which negatively impacted its E-vehicle sales revenue [4]. - Despite optimistic long-term projections, Fly-E's sales continued to decline, and operating expenses increased, leading to a failure in meeting revenue forecasts [4]. - The lawsuit claims that when the true information became public, investors suffered damages [4].

Core Viewpoint - Rosen Law Firm is reminding purchasers of WPP plc American Depositary Shares (ADS) of a class action lawsuit with a lead plaintiff deadline of December 8, 2025, for those who bought shares between February 27, 2025, and July 8, 2025 [1][2]. Group 1: Class Action Details - Investors who purchased WPP ADSs during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The lawsuit claims that WPP provided misleading statements about its media arm's capabilities, which led to significant market share loss and investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured over $438 million for investors in 2019 alone and has been consistently ranked among the top firms for securities class action settlements since 2013 [4].

Core Viewpoint - Rosen Law Firm is investigating potential breaches of fiduciary duties by the directors and officers of Semtech Corporation [1]. Group 1: Investigation Details - The investigation pertains to potential breaches of fiduciary duties by Semtech Corporation's leadership [1]. - Shareholders of Semtech Corporation are encouraged to visit the Rosen Law Firm's website for more information regarding the investigation [2]. Group 2: Rosen Law Firm's Background - Rosen Law Firm has a strong track record in securities class actions and shareholder derivative litigation, having achieved significant settlements for investors [3]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [3]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for shareholders [3].

Core Viewpoint - Rosen Law Firm is reminding investors who bought or sold Cepton, Inc. common stock between July 29, 2024, and January 6, 2025, of the December 8, 2025, lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court by December 8, 2025, to serve as lead plaintiff [3] - Investors can join the class action by visiting the provided link or contacting the law firm directly [6] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013 [4] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [4] Group 3: Case Allegations - The lawsuit alleges that Cepton's management made materially false and misleading statements regarding the company's business and operations [5] - Specific claims include that Cepton received a credible third-party bid valuing the company at more than double the Koito Acquisition, which was not disclosed to shareholders [5] - The Board of Directors allegedly failed to explore the third-party offer meaningfully, depriving shareholders of the opportunity to consider the acquisition [5]

Core Viewpoint - Rosen Law Firm has announced the filing of a class action lawsuit on behalf of purchasers of Marex Group plc securities during the specified Class Period, indicating potential legal issues surrounding the company's financial disclosures and practices [1][5]. Group 1: Class Action Details - The class action lawsuit is on behalf of purchasers of Marex securities between May 16, 2024, and August 5, 2025, and a previous class action has already been filed [1]. - Investors who purchased Marex securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by submitting a form or contacting the law firm directly, with a deadline to serve as lead plaintiff set for December 8, 2025 [3][6]. Group 2: Allegations Against Marex - The lawsuit alleges that Marex made materially false and misleading statements and failed to disclose critical information, including the sale of over-the-counter financial instruments to itself and inconsistencies in financial statements [5]. - It is claimed that Marex's financial statements could not be relied upon due to these issues, leading to misleading positive statements about the company's business and operations [5].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) for the period between March 10, 2024, and September 29, 2025, due to alleged misleading statements and failure to disclose material facts regarding the company's products [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that during the Class Period, defendants made false and/or misleading statements about the differences between Nanobodies and monoclonal antibodies, specifically regarding SLK and BIMZELX [5]. - Allegations include that SLK and BIMZELX share the same molecular targets, and that SLK's Nanobody structure does not provide superior clinical benefits over traditional monoclonal antibodies [5]. - The lawsuit asserts that when the true details were revealed, investors suffered damages due to the misleading information [5]. Group 2: Participation Information - Investors who purchased MoonLake common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must file a motion with the Court by December 15, 2025, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of F5, Inc. due to allegations of materially misleading business information issued by the company [1] Group 1 - The investigation is focused on F5, Inc. (NASDAQ: FFIV) and its communication to the investing public [1] - Shareholders who purchased F5 securities may be entitled to compensation without any out-of-pocket fees or costs through a contingency fee arrangement [1]